Akeila Bio is a biotech start-up company developing breakthrough medicines that target the retinoid X receptor (RXR) to treat a broad range of diseases driven by dysregulation of the immune system, glucose metabolism, and lipid metabolism.
Company Details
- Employees
- 2
- Founded
- 2022
- Address
- Ann Arbor, Mi 48105, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Ann Arbor, MI
Akeila Bio Questions
Akeila Bio's LinkedIn profile is https://www.linkedin.com/company/akeila-bio
Akeila Bio has
2 employees.
View email and phone details for 2
employees at Akeila Bio.
Akeila Bio's industry is
Biotechnology Research
Akeila Bio's top competitors are
Bioscience Navigators,
Modulant Biosciences,
Continuity Pharma,
Wicked Technologies,
Ruminant Biotech,
Cadmus Animal Health,
Extrinsic Immunity Therapeutics,
Onl Therapeutics,
Intero Biosystems,
Curio Genomics.
Akeila Bio's categories are Biotechnology Research
Akeila Bio's founding year is 2022
